At a special meeting yesterday, shareholders of interventional firm C.R. Bard approved the company's planned merger with a Tyco International subsidiary.
In the merger, each share of Bard common stock will be exchanged for 1.128 Tyco common shares. The transaction, which remains subject to U.S. and international regulatory approval and other customary conditions, is expected to close in the fourth quarter, according to Murray Hill, NJ-based Bard.
By AuntMinnie.com staff writersAugust 8, 2001
Related Reading
Tyco to acquire C.R. Bard, May 30, 2001
Bard gets clearance for biliary stent, April 17, 2001
Bard to test ePTFE-covered stent, March 8, 2001
Bard gets clearance for Luminexx, March 6, 2001
Tyco completes Mallinckrodt purchase after agreeing to settle antitrust issues, October 18, 2000
Copyright © 2001 AuntMinnie.com
